Cognitive patterns in relation to biomarkers of cerebrovascular disease and vascular risk factors

Cerebrovascular Diseases

Volumn 36, Issue 2, 2013, Pages 98-105

  Miralbell, Júlia ^a,c   López Cancio, Elena ^d   López Oloriz, Jorge ^b,c   Arenillas, Juan Francisco ^d   Barrios, Maite ^b   Soriano Raya, Juan José ^b   Galán, Amparo ^e   Cáceres, Cynthia ^d   Alzamora, Maite ^d   Pera, Guillem ^d   Toran, Pere ^d   Dávalos, Antoni ^d   Mataró, Maria ^b,c  

^a ICS IDIAP Jordi Gol   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c ICS IDIAP Jordi Gol   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Biomarkers; Cerebrovascular disease; Cognitive impairment; Inflammation; Thrombosis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; N(G),N(G) DIMETHYLARGININE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; COGNITION; DEPTH PERCEPTION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; SPEECH; THROMBOSIS; VERBAL FLUENCY; VERBAL MEMORY; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DEPRESSION; EDUCATION; HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE INDEX; MEDICAL PARAMETERS; MENTAL FUNCTION; MENTAL PERFORMANCE; VASCULAR COGNITIVE IMPAIRMENT; VASCULAR THROMBOSIS; VERY ELDERLY; VISUOSPATIAL SKILL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CEREBROVASCULAR DISORDERS; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; MEMORY; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 84885606485     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000352059     Document Type: Article

References (36)

1. O?Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al: Vascular cognitive impairment . Lancet Neurol 2003; 2: 89-98
2. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, et al: Research criteria for subcortical vascular dementia in clinical trials . J Neural Transm Suppl 2000; 59: 23-30
3. Jokinen H, Kalska H, Ylikoski R, Madureira S, Verdelho A, Gouw A, et al: MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study . Cerebrovasc Dis 2009; 27: 336-344
4. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al: National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards . Stroke 2006; 37: 2220-2241
5. Grau-Olivares M, Arboix A, Junqué C, Arenaza- Urquijo EM, Rovira M, Bartrés-Faz D: Progressive gray matter atrophy in lacunar patients with vascular mild cognitive impairment . Cerebrovasc Dis 2010; 30: 157-166
6. Cummings JL, Doody R, Clark C: Diseasemodifying therapies for Alzheimer disease: challenges to early intervention . Neurology 2007; 69: 1622-1634
7. Okonkwo OC, Cohen RA, Gunstad J, Tremont G, Alosco ML, Poppas A: Longitudinal trajectories of cognitive decline among older adults with cardiovascular disease . Cerebrovasc Dis 2010; 30: 362-373
8. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al: Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association . Stroke 2011; 42: 2672-2713
9. Solfrizzi V, D?Introno A, Colacicco AM, Capurso C, Todarello O, Pellicani V, et al: Circulating biomarkers of cognitive decline and dementia . Clin Chim Acta 2006; 364: 91-112
10. Kunz AB, Kraus J, Young P, Reuss R, Wipfler P, Oschmann P, et al: Biomarkers of inflammation and endothelial dysfunction in stroke with and without sleep apnea . Cerebrovasc Dis 2012; 33: 453-460
11. López-Cancio E, Galán A, Dorado L, et al: Biological signatures of asymptomatic extraand intracranial atherosclerosis: the Barcelona- AsIA (Asymptomatic Intracranial Atherosclerosis) study. Stroke 2012; 43: 2712-2719
12. Iadecola C, Park L, Capone C: Threats to the mind: aging, amyloid, and hypertension . Stroke 2009; 40:S40-S44
13. Kuo H, Yen C, Chang C, Kuo C, Chen J, Sorond F: Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis . Lancet Neurol 2005; 4: 371-380
14. Miralbell J, Soriano JJ, Spulber G, López-Cancio E, Arenillas JF, Bargalló N, et al: Structural brain changes and cognition in relation to markers of vascular dysfunction . Neurobiol Aging 2012; 33: 1003.e9-e17
15. Trollor JN, Smith E, Baune BT, Kochan NA, Campbell L, Samaras K, et al: Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study. Dement Geriatr Cogn Disord 2010; 30: 569-578
16. Stott DJ, Robertson M, Rumley A, Welsh P, Sattar N, Packard CJ, et al: Activation of hemostasis and decline in cognitive function in older people. Arterioscler Thromb Vasc Biol 2010; 30: 605-611
17. Selley ML: Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer?s disease. Neurobiol Aging 2003; 24: 903-907
18. Pikula A, Böger RH, Beiser AS, Maas R, De- Carli C, Schwedhelm E, et al: Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study . Stroke 2009; 40: 2959-2964
19. Kim J, Lee H, Park H, Kim S, Kang H, Kim N, et al: Endothelial function in lacunar infarction: a comparison of lacunar infarction, cerebral atherosclerosis and control group . Cerebrovasc Dis 2009; 28: 166-170
20. López-Cancio E, Dorado L, Millán M, Reverté S, Suñol A, Massuet A, et al: The population- based Barcelona-Asymptomatic Intracranial Atherosclerosis Study (AsIA): rationale and design . BMC Neurol 2011; 11: 22
21. López-Cancio E, Dorado L, Millán M, Reverté S, Suñol A, Massuet A, et al: The Barcelona- Asymptomatic Intracranial Atherosclerosis (AsIA) study: prevalence and risk factors . Atherosclerosis 2012; 221: 221-225
22. Marrugat J, Subirana I, Comín E, Cabezas C, Vila J, Elosua R, et al: Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health 2007; 61: 40-47
23. Alberti KG, Eckel RH, Grundy SM, et al, International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man . Diabetologia 1985; 28: 412-419
25. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R: Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Med Clin (Barc) 2001; 117: 530-533
26. Yesavage JA: Geriatric Depression Scale . Psychopharmacol Bull 1988; 24: 709-711
27. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, et al: Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001; 56: 42-48
28. Ingles JL, Boulton DC, Fisk JD, Rockwood K: Preclinical vascular cognitive impairment and Alzheimer disease: neuropsychological test performance 5 years before diagnosis . Stroke 2007; 38: 1148-1153
29. Saenger AK, Christenson RH: Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem 2010; 56: 21-33
30. Noble JM, Manly JJ, Schupf N, Tang MX, Mayeux R, Luchsinger JA: Association of Creactive protein with cognitive impairment . Arch Neurol 2010; 67: 87-92
31. Teunissen CE, van Boxtel MPJ, Bosma H, Bosmans E, Delanghe J, De Bruijn C, et al: Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 2003; 134: 142-150
32. Ravaglia G, Forti P, Maioli F, Chiappelli M, Montesi F, Tumini E, et al: Blood inflammatory markers and risk of dementia: the Conselice Study of Brain Aging . Neurobiol Aging 2007; 28: 1810-1820
33. Weuve J, Ridker PM, Cook NR, Buring JE, Grodstein F: High-sensitivity C-reactive protein and cognitive function in older women. Epidemiology 2006; 17: 183-189
34. Simpson JE, Fernando MS, Clark L, Ince PG, Matthews F, Forster G, et al: White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol 2007; 33: 410-419
35. Johnson DK, Storandt M, Morris JC, Langford ZD, Galvin JE: Cognitive profiles in dementia: Alzheimer disease versus healthy brain aging . Neurology 2008; 71: 1783-1789
36. Whiteley W, Wardlaw J, Dennis M, Lowe G, Rumley A, Sattar N, et al: Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study . Cerebrovasc Dis 2011; 32: 141-147